T. Rowe Price Associates’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $937K | Buy |
|
|||||
|
2025
Q2 | $689K | Buy |
|
|||||
|
2025
Q1 | $544K | Sell |
|
|||||
|
2024
Q4 | $610K | Buy |
|
|||||
|
2024
Q3 | $448K | Buy |
|
|||||
|
2024
Q2 | $406K | Sell |
|
|||||
|
2024
Q1 | $444K | Buy |
|
|||||
|
2023
Q4 | $517K | Sell |
|
|||||
|
2023
Q3 | $415K | Buy |
|
|||||
|
2023
Q2 | $445K | Buy |
|
|||||
|
2023
Q1 | $412K | Buy |
|
|||||
|
2022
Q4 | $415K | Sell |
|
|||||
|
2022
Q3 | $818K | Buy |
|
|||||
|
2022
Q2 | $646K | Buy |
|
|||||
|
2022
Q1 | $434K | Buy |
|
|||||
|
2021
Q4 | $454K | Sell |
|
|||||
|
2021
Q3 | $374K | Buy |
|
|||||
|
2021
Q2 | $520K | Sell |
|
|||||
|
2021
Q1 | $771K | Sell |
|
|||||
|
2020
Q4 | $7.93M | Sell |
|
|||||
|
2020
Q3 | $8.05M | Buy |
|
|||||
|
2020
Q2 | $11M | Buy |
|
|||||
|
2020
Q1 | $11.9M | Sell |
|
|||||
|
2019
Q4 | $13.6M | Buy |
|
|||||
|
2019
Q3 | $10.2M | Sell |
|
|||||
|
2019
Q2 | $18.6M | Sell |
|
|||||
|
2019
Q1 | $27.5M | Sell |
|
|||||
|
2018
Q4 | $31.6M | Sell |
|
|||||
|
2018
Q3 | $52.1M | Sell |
|
|||||
|
2018
Q2 | $39.5M | Sell |
|
|||||
|
2018
Q1 | $56.9M | Buy |
|
|||||
|
2017
Q4 | $64.6M | Buy |
|
|||||
|
2017
Q3 | $78.8M | Buy |
|
|||||
|
2017
Q2 | $52.6M | Buy |
|
|||||
|
2017
Q1 | $13.4M | Buy |
|
|||||
|
2016
Q4 | $9.19M | Sell |
|
|||||
|
2016
Q3 | $11.4M | Buy |
|
|||||
|
2016
Q2 | $4.78M | Buy |
|
|||||
|
2016
Q1 | $2.32M | Sell |
|
|||||
|
2015
Q4 | $2.23M | Sell |
|
|||||
|
2015
Q3 | $1.54M | Buy |
|
|||||
|
2015
Q2 | $1.62M | Buy |
|
|||||
|
2015
Q1 | $2.15M | Sell |
|
|||||
|
2014
Q4 | $5.12M | Sell |
|
|||||
|
2014
Q3 | $7.95M | Buy |
|
|||||
|
2014
Q2 | $3.31M | Buy |
|